State Biotechnology and Genomic Development: Critical Resources and Barriers

In: Politics & policy, Band 46, Heft 6, S. 985-1016

Abstract

AbstractThis article describes the development of an index of state biotechnology and genomic development and the cluster analysis used to group U.S. states based on their level of development in each area. Multivariate analysis of variance (MANOVA) is then used to test hypotheses regarding statistically significant differences between the biotechnology/genomic development clusters and variables related to states' workforce, investment in research and development (R&D), and policy environment. The authors find statistically significant results in the areas of workforce education, migration of knowledge workers, industrial and nonindustrial R&D, and policy to promote the development of the biotechnology industry. While the MANOVA for policies placing limits on the development of biotechnology policy did not yield statistical significance, the authors argue that the finding deserves further study as it may indicate some states' willingness to strike a more sustainable balance between support and regulation.Related ArticlesBrant, Hanna K., Nathan Myers, and Katherine L. Runge. 2017. "Promotion, Protection, and Entrepreneurship: Stakeholder Participation and Policy Change in the 21st Century Cures Initiative." Politics & Policy 45 (3), 372‐404. https://doi.org/10.1111/polp.12201Harvey, Olivia. 2009. "Human Embryonic Stem Cell Research in the United States: Some Policy Options for Industry Development." Politics & Policy 37 (1): 51‐71. https://doi.org/10.1111/j.1747-1346.2008.00161.xBerkovich, Simon. 2008. "Caution on Genetic Engineering Developments in View of Uncertainties of Modern Fundamental Science." Politics & Policy 37 (1): 1144‐1146. https://doi.org/10.1111/j.1747-1346.2008.00157_2.x